ACR Works to Eliminate Part B Drug Costs from MIPS Payment Adjustments

Kelly April Tyrrell writes about health, science and health policy. She lives in Madison, Wis.

References

1. Centers for Medicare and Medicaid Services. Medicare Program; CY 2018 updates to the Quality Payment Program. Federal Register. 2017 Jun 30;82(125). https://www.federalregister.gov/documents/2017/06/30/2017-13010/medicare-program-cy-2018-updates-to-the-quality-payment-program.
2. Specialists lobby to exclude drug costs from doctor pay calculations. Inside Health Policy. 2017 Sep 27;20(39). https://insidehealthpolicy.com/daily-news/specialists-lobby-congress-exclude-drug-costs-doctor-pay-calculations.
3. American Society of Clinical Oncology and American College of Rheumatology. Oppose inclusion of Medicare Part B drugs in QPP/MIPS payment adjustment. American Medical Association House of Delegates Resolution I-17. 2017. https://www.ama-assn.org/sites/default/files/media-browser/public/hod/i17-225.pdf.
4. Paulsen E. [Letter to Congressional colleagues, including an attached letter to Health and Human Services Secretary Tom Price.] 2017 Aug 25.
5. American Academy of Ophthalmology. Submissions to the Committee on Ways and Means Subcommittee on Health Regarding Statutory and Regulatory Burdens on Optimized Efficiency and Patient Care [letter]. 2017 Aug 1.